Common Stock, Shares, Outstanding of ARTELO BIOSCIENCES, INC. from 31 Aug 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ARTELO BIOSCIENCES, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Aug 2014 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 2,018,746, a 256% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 2,018,746 +1,451,164 +256% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 1,555,493 -1,672,207 -52% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 704,425 -2,523,275 -78% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 567,582 -2,660,118 -82% 31 Mar 2025 8-K 11 Jul 2025
Q4 2024 567,582 +35,932 +6.8% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 3,227,700 +65,346 +2.1% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 3,227,700 +372,012 +13% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 3,227,700 +372,012 +13% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 531,650 -2,324,038 -81% 31 Dec 2023 8-K 11 Jul 2025
Q3 2023 3,162,354 +306,666 +11% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,855,688 -39,738,293 -93% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 2,855,688 -39,445,325 -93% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 2,855,688 +35,620 +1.3% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 2,855,688 +1,220,579 +75% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 42,593,981 +19,444,869 +84% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 42,301,013 +20,087,901 +90% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 2,820,068 -12,291,519 -81% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 1,635,109 -3,356,478 -67% 31 Aug 2021 10-K 31 Mar 2023 2022 FY
Q2 2021 23,149,112 +19,415,508 +520% 31 May 2021 10-Q 12 Jul 2021 2021 Q3
Q1 2021 22,213,112 +18,785,713 +548% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 15,111,587 +11,685,311 +341% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 4,991,587 +1,637,971 +49% 31 Aug 2020 10-KT 21 Mar 2022 2022 Q1
Q2 2020 3,733,604 +1,632,464 +78% 31 May 2020 10-Q 13 Jul 2020 2020 Q3
Q1 2020 3,427,399 -12,252,090 -78% 29 Feb 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 3,426,276 -10,803,744 -76% 30 Nov 2019 10-Q 14 Jan 2020 2020 Q1
Q3 2019 3,353,616 +1,603,348 +92% 31 Aug 2019 10-K 04 Nov 2020 2020 FY
Q2 2019 2,101,140 -10,680,055 -84% 31 May 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 15,679,489 +3,311,600 +27% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 14,230,020 +2,877,718 +25% 30 Nov 2018 10-Q 14 Jan 2019 2019 Q1
Q3 2018 1,750,268 -9,577,034 -85% 31 Aug 2018 10-K/A 18 Dec 2019 2019 FY
Q2 2018 12,781,195 +2,981,195 +30% 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 12,367,889 +4,727,889 +62% 28 Feb 2018 10-Q/A 14 May 2018 2018 Q2
Q4 2017 11,352,302 +3,712,302 +49% 30 Nov 2017 10-Q/A 21 Mar 2018 2018 Q1
Q3 2017 11,327,302 +3,687,302 +48% 31 Aug 2017 10-K 29 Nov 2018 2018 FY
Q2 2017 9,800,000 +2,160,000 +28% 31 May 2017 10-Q 21 Jul 2017 2017 Q3
Q1 2017 7,640,000 0 0% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 7,640,000 0 0% 30 Nov 2016 10-Q 10 Jan 2017 2017 Q1
Q3 2016 7,640,000 0 0% 31 Aug 2016 10-K 29 Nov 2017 2017 FY
Q2 2016 7,640,000 +790,000 +12% 31 May 2016 10-Q 05 Jul 2016 2016 Q3
Q1 2016 7,640,000 +1,640,000 +27% 29 Feb 2016 10-Q 01 Apr 2016 2016 Q2
Q4 2015 7,640,000 30 Nov 2015 10-Q 14 Jan 2016 2016 Q1
Q3 2015 7,640,000 +1,640,000 +27% 31 Aug 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 6,850,000 31 May 2015 10-Q 15 Jul 2015 2015 Q3
Q1 2015 6,000,000 28 Feb 2015 10-Q 14 Apr 2015 2015 Q2
Q3 2014 6,000,000 31 Aug 2014 10-K 11 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.